首页> 外文期刊>Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association >Daily peritoneal ultrafiltration predicts patient and technique survival in anuric peritoneal dialysis patients.
【24h】

Daily peritoneal ultrafiltration predicts patient and technique survival in anuric peritoneal dialysis patients.

机译:每日腹膜超滤可预测无尿腹膜透析患者的患者和技术存活率。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Maintenance dialysis therapy is the only way to remove excess fluid in patients with anuric end-stage renal disease. The optimal ultrafiltration (UF) volume in patients on peritoneal dialysis (PD) remains controversial. METHODS: We retrospectively analysed a cohort of 86 prevalent anuric PD patients followed up for a median of 25.3 months (range, 6 to 54 months). Clinical and PD parameters were recorded yearly. Kaplan-Meier analysis and Cox proportional hazards models were used to identify risk factors of mortality and technique failure in patients with a UF >/=1 L/24 h or <1 L/24 h. RESULTS: When compared to those with a UF <1 L/24 h, patients with a UF >/=1 L/24 h had significantly higher haemoglobin levels (101.9 +/- 20.5 vs 89.3 +/- 20.2 g/L, P < 0.05) and tended to be younger (55.0 +/- 12.5 vs 60.6 +/- 16.1 years, P = 0.10). Also, while Kt/V and CCr were stable over time, UF decreased significantly over the study period (baseline, 1205.5 +/- 327.3 ml/24 h vs after 3 years, 870.6 +/- 439.8 ml/24 h; P < 0.001). Using Kaplan-Meier analysis, patients with baseline UF <1 L/24 h had significantly worse outcome (survival, 27.2 +/- 3.9 vs 42.4 +/- 1.9 months; P < 0.001). In multivariate Cox regression analysis, age, time-dependent UF volume and serum albumin were independent predictors of mortality, while UF independently predicted technique failure. CONCLUSIONS: The present study demonstrates a strong predictive value of daily peritoneal UF for both technique and patient survival in prevalent anuric PD patients. Identifying markers of satisfactory fluid status, as well as optimizing therapy to meet UF goals, remains an important clinical target.
机译:背景:维持性透析疗法是去除患有无水性终末期肾病的患者过多液体的唯一方法。腹膜透析(PD)患者的最佳超滤(UF)量仍存在争议。方法:我们回顾性分析了86例流行性无尿PD患者的随访情况,中位时间为25.3个月(6至54个月)。每年记录临床和PD参数。使用Kaplan-Meier分析和Cox比例风险模型确定UF> / = 1 L / 24 h或<1 L / 24 h的患者的死亡和技术失败的危险因素。结果:与UF <1 L / 24 h的患者相比,UF> / = 1 L / 24 h的患者血红蛋白水平显着更高(101.9 +/- 20.5 vs 89.3 +/- 20.2 g / L,P <0.05)并趋于年轻(55.0 +/- 12.5 vs 60.6 +/- 16.1岁,P = 0.10)。同样,尽管Kt / V和CCr随时间稳定,但UF在研究期间显着降低(基线,1205.5 +/- 327.3 ml / 24 h与3年后的870.6 +/- 439.8 ml / 24 h; P <0.001 )。使用Kaplan-Meier分析,基线UF <1 L / 24 h的患者预后明显较差(生存期为27.2 +/- 3.9个月vs 42.4 +/- 1.9个月; P <0.001)。在多变量Cox回归分析中,年龄,时间依赖性超滤量和血清白蛋白是死亡率的独立预测因子,而超滤则独立预测技术失败。结论:本研究证明了在无尿PD患者中,每日腹膜超滤对于技术和患者生存率均具有很强的预测价值。确定令人满意的体液状态的标志物以及优化治疗以达到超滤目标仍然是重要的临床目标。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号